- Palabras clave > Action Programme on Essential Drugs
- Palabras clave > advocacy
- Palabras clave > medicines policy - support
- Palabras clave > partnership
- Palabras clave > pharmaceutical regulation
- Palabras clave > rational use of medicines (RUM) / rational medicine use (RMU)
- Palabras clave > technical assistance
(1991; 1 page)
In 1990 the American Public Health Association (APHA) adopted a position paper called “Medicines in Developing Countries: A Global Health Concern” as official policy of the Association. This article describes the new policy’s objectives and implications. The policy aims to increase promotion of rational drug use within primary health care facilities of developing countries and recognition of the WHO Action Programme on Essential Drugs and Vaccines. The objectives are broken down into categories relative to three groups: the pharmaceutical industry, the WHO Action Programme, and Member States of the WHO. The details of each category’s objectives are listed in the article. The APHA is also planning to initiate several activities to promote the Action Programme by working with other groups including the World Federation of Public Health Associations, the United States Congress, and the World Federation. The article also mentions the formation of an Advisory Group on Medicines in Developing Countries which will implement the actions called for in the policy paper. The first meeting of the Advisory Group is scheduled for 10-14 November 1991 in Atlanta, Georgia.
Abstract written by M. Tobin, 2013.